Marcheselli L - Search Results

1

Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.

Grandi G, Toss A, Cagnacci A, Marcheselli L, Pavesi S, Facchinetti F, Cascinu S, Cortesi L. Grandi G, et al. Among authors: marcheselli l. Clin Breast Cancer. 2018 Feb;18(1):e15-e24. doi: 10.1016/j.clbc.2017.10.016. Epub 2017 Nov 14. Clin Breast Cancer. 2018. PMID: 29150351

2

Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.

Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C. Iannitto E, et al. Among authors: marcheselli l. Haematologica. 2024 Jul 1;109(7):2297-2302. doi: 10.3324/haematol.2023.284109. Haematologica. 2024. PMID: 38497158 Free PMC article. Clinical Trial. No abstract available.

3

Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.

Cortesi L, Barchetti A, De Matteis E, Rossi E, Della Casa L, Marcheselli L, Tazzioli G, Lazzaretti MG, Ficarra G, Federico M, Iannone A. Cortesi L, et al. Among authors: marcheselli l. J Proteome Res. 2009 Nov;8(11):4916-33. doi: 10.1021/pr900239h. J Proteome Res. 2009. PMID: 19739612

4

Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years.

Cortesi L, Marcheselli L, Guarneri V, Cirilli C, Braghiroli B, Toss A, Sant M, Ficarra G, Conte PF, Federico M. Cortesi L, et al. Among authors: marcheselli l. Int J Cancer. 2013 Jan 15;132(2):E58-65. doi: 10.1002/ijc.27795. Epub 2012 Sep 21. Int J Cancer. 2013. PMID: 22915138 Free article.

5

Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on Italian women.

Cortesi L, De Matteis E, Cirilli C, Marcheselli L, Proietto M, Federico M. Cortesi L, et al. Among authors: marcheselli l. Tumori. 2012 Nov;98(6):743-50. doi: 10.1177/030089161209800611. Tumori. 2012. PMID: 23389361

6

Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.

Colaci M, Giuggioli D, Vacchi C, Lumetti F, Iachetta F, Marcheselli L, Federico M, Ferri C. Colaci M, et al. Among authors: marcheselli l. Autoimmun Rev. 2014 Feb;13(2):132-7. doi: 10.1016/j.autrev.2013.09.006. Epub 2013 Oct 6. Autoimmun Rev. 2014. PMID: 24103404 Review.

7

Twenty-years experience with de novo metastatic breast cancer.

Cortesi L, Toss A, Cirilli C, Marcheselli L, Braghiroli B, Sebastiani F, Federico M. Cortesi L, et al. Among authors: marcheselli l. Int J Cancer. 2015 Sep 15;137(6):1417-26. doi: 10.1002/ijc.29503. Epub 2015 Mar 23. Int J Cancer. 2015. PMID: 25736070

8

Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.

Marcheselli R, Marcheselli L, Cortesi L, Bari A, Cirilli C, Pozzi S, Ferri P, Napolitano M, Federico M, Sacchi S. Marcheselli R, et al. Among authors: marcheselli l. J Breast Cancer. 2015 Dec;18(4):378-85. doi: 10.4048/jbc.2015.18.4.378. Epub 2015 Dec 23. J Breast Cancer. 2015. PMID: 26770245 Free PMC article.

9

The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.

Toss A, Grandi G, Cagnacci A, Marcheselli L, Pavesi S, De Matteis E, Razzaboni E, Tomasello C, Cascinu S, Cortesi L. Toss A, et al. Among authors: marcheselli l. Oncotarget. 2017 Feb 7;8(6):9144-9154. doi: 10.18632/oncotarget.13423. Oncotarget. 2017. PMID: 27880720 Free PMC article.

10

The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy.

Salati M, Caputo F, Cunningham D, Marcheselli L, Spallanzani A, Rimini M, Gelsomino F, Reggiani-Bonetti L, Andrikou K, Rovinelli F, Smyth E, Baratelli C, Kouvelakis K, Kalaitzaki R, Gillbanks A, Michalarea V, Cascinu S, Braconi C. Salati M, et al. Among authors: marcheselli l. Eur J Cancer. 2019 Aug;117:84-90. doi: 10.1016/j.ejca.2019.05.030. Epub 2019 Jul 2. Eur J Cancer. 2019. PMID: 31276980 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters